Nathan John Lachowsky1, Zach Tanner, Zishan Cui, Paul Sereda, Asheligh Rich, Jody Jollimore, Julio Sg Montaner, Robert S Hogg, David M Moore, Eric A Roth. 1. From the *Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS; †Division of AIDS, Faculty of Medicine, University of British Columbia; ‡School of Public Health and Social Policy, University of Victoria, Victoria; §Health Initiative for Men, Vancouver; ¶Faculty of Health Sciences, Simon Fraser University, Burnaby; and ∥Department of Anthropology, University of Victoria; and**Centre for Addictions Research of British Columbia, Victoria, Canada.
Abstract
BACKGROUND: We sought to identify factors associated with condom use during anal intercourse among self-identified human immunodeficiency virus-negative gay, bisexual, and other men who have sex with men (GBM) in Vancouver, Canada following "treatment as prevention" (TasP) scale-up in 2010. METHODS: Sexually active GBM were recruited using respondent-driven sampling from 2012 to 2014. We analyzed participants' most recent sexual encounter with up to their last 5 sexual partners within the past 6 months. In addition to individual- and event-level explanatory factors, we assessed potential associations with TasP awareness, TasP-related prevention practice (viral load sorting), and TasP-related attitudes (human immunodeficiency virus treatment optimism). Accounting for clustering at the respondent-driven sampling chain-level and participant-level, factors associated with event-level condom use versus nonuse were determined using a multivariable generalized linear mixed model built using backward selection and AIC minimization. RESULTS: Of 513 participants, 436 GBM (85%) reported a total of 1196 anal sex events with 56% condom use. The proportion of condom-protected sexual events decreased monthly over the study period (odds ratio [OR], 0.95 per month, 95% confidence interval [CI], 0.92-0.98). The TasP practices and attitudes were significantly associated with lower odds of condom use at the univariate level, but were no longer significant at multivariate level. In the multivariable model, event-level partner methamphetamine use (adjusted OR [aOR], 0.18; 95% CI, 0.06-0.58), frequency of recent anal intercourse with that partner (aOR, 0.97 per act; 95% CI, 0.95-0.98) and time since first sex with that partner (aOR, 0.97 per 6 months; 95% CI, 0.95-0.99) were associated with lower odds of condom use, whereas event-level participant alcohol use (aOR, 1.41; 95% CI, 1.01-1.98) and no planned future sex with that partner (aOR, 1.56; 95% CI, 1.08-2.27) were associated with greater odds of condom use. Event-level receptive-only (aOR, 2.10; 95% CI, 1.38-3.20) or insertive-only (aOR, 2.53; 95% CI, 1.64-3.90) sexual positions were associated with greater odds of condom use compared with reporting both positions. CONCLUSIONS: The TasP-related factors were not the most salient predictors of GBM's condom use. Health promotion must consider associations between condomless anal sex and substance use and relational factors.
BACKGROUND: We sought to identify factors associated with condom use during anal intercourse among self-identified human immunodeficiency virus-negative gay, bisexual, and other men who have sex with men (GBM) in Vancouver, Canada following "treatment as prevention" (TasP) scale-up in 2010. METHODS: Sexually active GBM were recruited using respondent-driven sampling from 2012 to 2014. We analyzed participants' most recent sexual encounter with up to their last 5 sexual partners within the past 6 months. In addition to individual- and event-level explanatory factors, we assessed potential associations with TasP awareness, TasP-related prevention practice (viral load sorting), and TasP-related attitudes (human immunodeficiency virus treatment optimism). Accounting for clustering at the respondent-driven sampling chain-level and participant-level, factors associated with event-level condom use versus nonuse were determined using a multivariable generalized linear mixed model built using backward selection and AIC minimization. RESULTS: Of 513 participants, 436 GBM (85%) reported a total of 1196 anal sex events with 56% condom use. The proportion of condom-protected sexual events decreased monthly over the study period (odds ratio [OR], 0.95 per month, 95% confidence interval [CI], 0.92-0.98). The TasP practices and attitudes were significantly associated with lower odds of condom use at the univariate level, but were no longer significant at multivariate level. In the multivariable model, event-level partner methamphetamine use (adjusted OR [aOR], 0.18; 95% CI, 0.06-0.58), frequency of recent anal intercourse with that partner (aOR, 0.97 per act; 95% CI, 0.95-0.98) and time since first sex with that partner (aOR, 0.97 per 6 months; 95% CI, 0.95-0.99) were associated with lower odds of condom use, whereas event-level participantalcohol use (aOR, 1.41; 95% CI, 1.01-1.98) and no planned future sex with that partner (aOR, 1.56; 95% CI, 1.08-2.27) were associated with greater odds of condom use. Event-level receptive-only (aOR, 2.10; 95% CI, 1.38-3.20) or insertive-only (aOR, 2.53; 95% CI, 1.64-3.90) sexual positions were associated with greater odds of condom use compared with reporting both positions. CONCLUSIONS: The TasP-related factors were not the most salient predictors of GBM's condom use. Health promotion must consider associations between condomless anal sex and substance use and relational factors.
Authors: Roberta E Emetu; Alexandra Marshall; Stephanie A Sanders; William L Yarber; Robin R Milhausen; Richard A Crosby; Cynthia A Graham Journal: J Am Coll Health Date: 2014
Authors: Paul Van de Ven; Limin Mao; Andrea Fogarty; Patrick Rawstorne; June Crawford; Garrett Prestage; Andrew Grulich; John Kaldor; Susan Kippax Journal: AIDS Date: 2005-01-28 Impact factor: 4.177
Authors: Viviane D Lima; Richard Harrigan; Melanie Murray; David M Moore; Evan Wood; Robert S Hogg; Julio Sg Montaner Journal: AIDS Date: 2008-11-12 Impact factor: 4.177
Authors: Nathan J Lachowsky; Sally Y Lin; Mark W Hull; Zishan Cui; Paul Sereda; Jody Jollimore; Ashleigh Rich; Julio S G Montaner; Eric A Roth; Robert S Hogg; David M Moore Journal: AIDS Behav Date: 2016-07
Authors: N J Lachowsky; C E Dewey; N P Dickson; P J W Saxton; A J Hughes; R R Milhausen; A J S Summerlee Journal: Sex Transm Infect Date: 2015-01-20 Impact factor: 3.519
Authors: Andrew N Phillips; Valentina Cambiano; Fumiyo Nakagawa; Alison E Brown; Fiona Lampe; Alison Rodger; Alec Miners; Jonathan Elford; Graham Hart; Anne M Johnson; Jens Lundgren; Valerie C Delpech Journal: PLoS One Date: 2013-02-15 Impact factor: 3.240
Authors: Allison Carter; Nathan Lachowsky; Ashleigh Rich; Jamie I Forrest; Paul Sereda; Zishan Cui; Eric Roth; Angela Kaida; David Moore; Julio Sg Montaner; Robert S Hogg Journal: J Int AIDS Soc Date: 2015-08-11 Impact factor: 5.396
Authors: Lindsay Shaw; Lu Wang; Zishan Cui; Ashleigh J Rich; Heather L Armstrong; Nathan J Lachowsky; Paul Sereda; Kiffer G Card; Gbolahan Olarewaju; David Moore; Robert Hogg; Eric Abella Roth Journal: J Sex Res Date: 2019-08-28
Authors: Sean P Colyer; Nathan J Lachowsky; Zishan Cui; Julia Zhu; Heather L Armstrong; Matthew Taylor; Joshua Edward; Gbolahan Olarewaju; Robert S Hogg; Eric A Roth; David M Moore Journal: Drug Alcohol Depend Date: 2018-02-08 Impact factor: 4.492
Authors: Kiffer G Card; Nathan J Lachowsky; Heather L Armstrong; Zishan Cui; Lu Wang; Paul Sereda; Jody Jollimore; Thomas L Patterson; Trevor Corneil; Robert S Hogg; Eric A Roth; David M Moore Journal: Addict Behav Date: 2018-03-06 Impact factor: 3.913
Authors: Kiffer G Card; Heather L Armstrong; Nathan J Lachowsky; Zishan Cui; Paul Sereda; Allison Carter; Julio S G Montaner; Robert S Hogg; Eric A Roth; David M Moore Journal: J Acquir Immune Defic Syndr Date: 2018-01-01 Impact factor: 3.731
Authors: R J Fredericksen; B M Whitney; E Trejo; R M Nance; E Fitzsimmons; F L Altice; A W Carrico; C M Cleland; C Del Rio; A Duerr; W M El-Sadr; S Kahana; I Kuo; K Mayer; S Mehta; L J Ouellet; V M Quan; J Rich; D W Seal; S Springer; F Taxman; W Wechsberg; H M Crane; J A C Delaney Journal: BMC Public Health Date: 2021-11-04 Impact factor: 3.295